Community Pharmacy England CEO Janet Morrison gave an update at this week’s Pharmacy Show while other members of the team engaged with visitors to our exhibition stand. Thank you to all community pharmacy owners and others who took this opportunity to engage with us, sharing views and asking questions. In a Q&A session on the
Read moreFollowing discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (19/10/2023) announced the following list of price concessions for October 2023: Drug Pack Size Price Concession Aciclovir 800mg tablets 35 £3.60 Atorvastatin 80mg tablets 28 £5.22 Benzoyl peroxide 5% / Clindamycin
Read moreCommunity Pharmacy England has released a set of resources on the price concessions system to further explain how this works and highlight some of our work in this area. The many challenges surrounding medicines supply and pricing have intensified, putting considerable pressure on community pharmacy owners and their teams. The disruption often causes problems in
Read moreFollowing discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (16/10/2023) announced the following initial list of price concessions for October 2023: Drug Pack Size Price concession Amisulpride 100mg tablets 60 £18.00 Atorvastatin 10mg tablets 28 £1.30 Atorvastatin
Read moreToday at The Pharmacy Show, a new Advanced service to supply eligible patients with COVID-19 Lateral Flow Device (LFD) test kits has been announced. The service, which is funded outside of the CPCF global sum, will allow eligible patients who have risk factors for progression to severe COVID-19 to obtain LFD test kits from participating
Read moreCommunity Pharmacy England held a pharmacy event and spread the word more widely about the sector’s challenges and potential at this year’s Labour Party conference in Liverpool. This followed on from the Conservative Party conference which you can read about here and built on our ongoing work to ensure the Shadow Health Team are well
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Bumetanide 1mg and 5mg tablets. MSN/2023/094 Tier 3 – high impact Date of issue 12th October 2023 Bumetanide 5mg tablets are out of stock until early March 2024. Bumetanide 1mg tablets remain available until the end of October and will be
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Azithromycin (Azyter®) 15mg/g eye drops (0.25g unit dose, preservative free). MSN/2023/096 Tier 2 – medium impact Date of issue 12th October 2023 Azithromycin (Azyter®) 15mg/g eye drops are out of stock from mid-October to mid-November 2023. Alternative topical and oral antibiotics
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Pancrease® HL gastro-resistant capsules. MSN/2023/095 Tier 2 – medium impact Date of issue 12th October 2023 Pancrease® HL gastro-resistant capsules are being discontinued with stock expected to be exhausted by mid-November 2023. Alternative high strength pancreatin preparations remain available and will
Read moreChanges to the Human Medicines Regulations 2023 came into effect today (11th October) which provides new rules requiring pharmacists to dispense all licensed medicines containing valproate in the manufacturer’s original full pack. When dispensing valproate products, the pharmacist must supply the product as a complete pack. This will require them to round up or down
Read more
